AUDREY HEWITT: Open Payments
NPI 1649621780 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,941 in 250 payments from 19 companies in 2025. Trend: 2023 $3,754 · 2024 $3,883 · 2025 $3,941
Food & beverage: $3,702Education: $239
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 42 | $734 |
| Janssen Biotech, Inc. | 24 | $537 |
| ABBVIE INC. | 37 | $464 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 25 | $432 |
| PFIZER INC. | 20 | $340 |
| Novartis Pharmaceuticals Corporation | 25 | $277 |
| E.R. Squibb & Sons, L.L.C. | 9 | $226 |
| UCB, Inc. | 11 | $186 |
| LEO Pharma Inc. | 21 | $175 |
| Organon LLC | 16 | $158 |
Products named: NEMLUVIO, TREMFYA, RINVOQ, CIBINQO, Sotyktu, Leqselvi, Bimzelx, ADBRY.
Industry payments across IN — which companies pay providers there.
